Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Pharmasset Inc (VRUS)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsSep-30-11Sep-30-10Sep-30-09Sep-30-08Sep-30-07Sep-30-06Dec-31-04Dec-31-03
   10-K10-K10-K10-K10-K10-KS-1/AS-1/A
Revenues  0.91.013.344.922.05,424.62.81.0
            Revenue growth  -12.1%-92.3%-70.4%103.8%-99.6% 162.9%-71.6%
Cost of goods sold  0.00.00.043.00.010,497.75.34.8
Gross profit  0.91.013.31.922.0-5,073.1-2.6-3.8
            Gross margin  100.0%100.0%100.0%4.1%100.0%-93.5%-93.1%-359.3%
Selling, general and administrative   [+]16.716.513.413.39.27,911.52.91.8
Research and development  75.948.352.6 20.3   
EBITDA   [+]-91.0-62.8-51.6-53.4-6.6-12,984.0397.3 
            EBITDA margin  -10145.6%-6160.9%-388.5%-119.1%-30.1%-239.4%14432.2%-527.4%
Depreciation  0.60.50.50.50.40.4264.3 
EBITA  -91.6-63.4-52.1-53.9-7.0-12,984.3133.0-5.5
            EBITA margin  -10212.3%-6213.0%-392.2%-120.3%-32.0%-239.4%4831.1%-527.4%
Amortization of intangibles   0.30.50.50.50.3138.5 
EBIT   [+]-91.6-63.7-52.6-54.4-7.5-12,984.6-5.5-5.5
            EBIT margin  -10212.3%-6245.0%-395.9%-121.3%-34.2%-239.4%-198.4%-527.4%
Interest expense, net   [+]1.02.43.02.2    
Other income (expense), net  0.5  2.0 1,659.00.50.2
Pre-tax income  -92.2-66.1-55.6-54.7-5.1-11,325.7-5.0-5.3
Income taxes  -1.00.00.00.00.00.00.00.3
            Tax rate  1.1%0.0%0.0%0.0%0.0%0.0%  
Net income  -91.2-66.1-55.6-54.7-6.8-12,436.60.00.0
            Net margin  -10165.6%-6478.6%-418.2%-121.9%-31.1%-229.3%0.0%0.0%
   
Basic EPS   [+]($1.25)($1.07)($1.05)($2.51)($0.46)($1,188.70)  
Diluted EPS   [+]($1.25)($1.07)($1.05)($2.51)($0.46)($1,188.70)  
   
Shares outstanding (basic)   [+]72.861.953.021.815.010.5  
Shares outstanding (diluted)   [+]72.861.953.021.815.010.5  
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy